Acceptable Analytical Practices for Dissolution Testing of Poorly Soluble Compounds

Published on: 
Pharmaceutical Technology, Pharmaceutical Technology-12-02-2004, Volume 28, Issue 11

This article provides guidance for developing dissolution testing for poorly soluble compounds. It is the second of a series of articles based on material from a 2003 PhRMA workshop about acceptable analytical practices.

Related Content:

AnalyticsProcess ValidationManufacturingQuality SystemsPharmaceutical Technology-12-02-2004
Curia and Corning Collaborate to Advance Biopharmaceutical Continuous-Flow Development
Feds to Review March-In Authority on Drug Patents
Invitae and Deerfield Management Team Up on Novel Therapeutics for Rare Diseases